No Increase in Clots With Drug-Eluting Stents

...ents developing stent thrombosis whether they were taking the blood thinner angiomax (bivalirudin) or heparin plus glycoprotein IIb/IIIa inhibitors, which also help prevent clots from forming. Although patients treated with angiomax had a higher rate of acute stent thrombosis, both groups had equal rates of...

Angiomax in Medical Technology

Angiomax Will Retain Decision Resources' Proprietary Clinical Gold Standard Status Over Current and New Therapies, Including Recently-Approved Efient, for the Treatment of NSTEMI

... angiomax Will Remain the NSTEMI Market Share Leader Through 2017, According to a New...een Efficacy and Safety finds that a drug that reduces mortality more than angiomax at 30 days with significantly lower rates of bleeding would earn a 50 perce...

CHMP Recommends Expanded Use of Angiox(R) (Bivalirudin) in Europe for Patients With Acute Coronary Syndromes

...an Economic Area. In the United States, a similar angiomax ACS filing is being reviewed by the U.S. Food and ...at http://www.angiox.com . In the United States, angiomax is indicated for use as an anticoagulant in patien...undergoing PCI. The most common adverse events for angiomax in clinical trials comparing...

Acuity One-Year Findings Meet All Primary Endpoints in Favor of Angiomax (Bivalirudin) Alone Treatment Group

...ear, the mortality rate of patients treated in the angiomax alone treatment group was 3.8%, compared to 4.4% i... therapy. Specifically, in patients treated in the angiomax alone group, the angiomax plus GPI group and the heparin plus GPI group, res...